Skip to main content

Animations

MJFF Publications

5281 - 5290 of 6284 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Circulating blood circular RNA in Parkinson’s Disease; from involvement in pathology to diagnostic tools in at-risk individuals
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00839-3
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A multi-region single nucleus transcriptomic atlas of Parkinson’s disease
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-024-04117-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: PathogenicLRRK2mutations cause loss of primary cilia and Neurturin in striatal parvalbumin interneurons
    Journal Name: Life Science Alliance
    Publisher: Life Science Alliance, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.26508/lsa.202402922
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Long‐Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29610
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.14360
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.30019
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Opto-Avoidance-Elevated Plus Maze protocol to study positive or negative valence upon optogenetic stimulation in the mouse brain
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2024.103474
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Brain age in genetic and idiopathic Parkinson's disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae382
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Mitochondrial oxidant stress promotes α-synuclein aggregation and spreading in mice with mutated glucocerebrosidase
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00842-8
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-024-01972-8
    Citation Count: 22
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.